Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Mar 31;18(1):113.
doi: 10.1186/s12882-017-0530-9.

Plasma Urotensin II levels in children and adolescents with chronic kidney disease: a single-centre study

Anastasia Garoufi  1 , Styliani Drapanioti  2 , Antonios Marmarinos  3 , Varvara Askiti  4 , Andromachi J Mitsioni  4 , Maria Mila  4 , Georgia Grigoriadou  5 , Dimitrios Georgakopoulos  5 , Constantinos J Stefanidis  4 , Dimitrios Gourgiotis  3
Affiliations

Plasma Urotensin II levels in children and adolescents with chronic kidney disease: a single-centre study

Anastasia Garoufi et al. BMC Nephrol. .

Abstract

Background: Increased plasma Urotensin II (UII) levels have been found in adults with renal diseases. Studies in children are scarce. The objective of the study is to estimate plasma UII levels in subjects with chronic kidney disease (CKD) stages 3 to 5 and renal transplant recipients (RTR). In addition, the correlation of UII with anthropometric features and biochemical parameters was assessed.

Methods: Fifty-four subjects, aged 3 to 20 years old, 23 with CKD, 13 with end-stage kidney disease (ESKD) undergoing hemodialysis (HD) and 18 RTR were enrolled. A detailed clinical evaluation was performed. Biochemical parameters of renal and liver function were measured. Plasma UII levels were measured in all patients and in 117 healthy controls, using a high sensitive enzyme immunoassay (EIA) kit. All data were analyzed using STATA™ (Version 10.1).

Results: Median UII and mean log-transformed UII levels were significantly higher in CKD and RTR patients compared to healthy subjects (p < 0.001). HD patients had higher but not statistically significant UII and log-UII levels than controls. UII levels increased significantly at the end of the HD session and were higher than controls and in line to those of other patients. The geometric scores of UII in HD (before dialysis), CKD and RTR patients increased respectively by 42, 136 and 164% in comparison with controls. Metabolic acidosis was associated with statistical significant change in log-UII levels (p = 0.001). Patients with metabolic acidosis had an increase in UII concentration by 76% compared to those without acidosis.

Conclusions: Children and adolescents with CKD, particularly those who are not on HD and RTR, have significantly higher levels of UII than healthy subjects. UII levels increase significantly at the end of the HD session. The presence of metabolic acidosis affects significantly plasma UII levels.

Keywords: Acidosis; End-stage kidney disease; Hemodialysis; Renal failure; Renal transplantation.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Distribution of plasma Urotensin II levels and log-transformed UII levels in patients
Fig. 2
Fig. 2
Box plot of UII levels by group. CKD: chronic Kidney Disease, HD: Hemodialysis, RTR: Renal Transplant Recipients
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Ames RS, Sarau HM, Chambers JK, Willette RN, Aiyar NV, Romanic AM, et al. It is a potent vasoconstrictor and agonist for the orphan recepror GPR14. Nature. 1999;401:282–286. doi: 10.1038/45809. - DOI - PubMed
    1. Bottrill FE, Douglas SA, Hiley CR, White R. Human urotensin-II is an endothelium-dependent vasodilator in rat small arteries. Br J Pharmacol. 2000;130:1865–1870. doi: 10.1038/sj.bjp.0703513. - DOI - PMC - PubMed
    1. Affolter J, Webb DJ. Urotensin II; a new mediator in cardiopulmonary regulation? Lancet. 2001;358:774–775. doi: 10.1016/S0140-6736(01)06005-6. - DOI - PubMed
    1. Charles CJ, Rademaker MT, Richards AM, Yandle TG. Urotensin II: Evidence for cardiac, hepatic and renal production. Peptides. 2005;26:2211–2214. doi: 10.1016/j.peptides.2005.03.043. - DOI - PubMed
    1. Mosenkis A, Danoff TM, Aiyar N, Bazeley J, Townsend RR. Human urotensin II in the plasma of anephric subjects. Nephrol Dial Transplant. 2007;22:1269–1270. doi: 10.1093/ndt/gfl697. - DOI - PubMed